Does DEGARELIX Cause Disseminated intravascular coagulation? 14 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Disseminated intravascular coagulation have been filed in association with DEGARELIX (FIRMAGON). This represents 0.4% of all adverse event reports for DEGARELIX.
14
Reports of Disseminated intravascular coagulation with DEGARELIX
0.4%
of all DEGARELIX reports
8
Deaths
8
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From DEGARELIX?
Of the 14 reports, 8 (57.1%) resulted in death, 8 (57.1%) required hospitalization, and 3 (21.4%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEGARELIX. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does DEGARELIX Cause?
Injection site pain (296)
Injection site erythema (246)
Hot flush (199)
Fatigue (195)
Injection site swelling (183)
Product storage error (177)
Pyrexia (170)
Off label use (128)
Asthenia (123)
Death (120)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which DEGARELIX Alternatives Have Lower Disseminated intravascular coagulation Risk?
DEGARELIX vs DELAFLOXACIN MEGLUMINE
DEGARELIX vs DELAMANID
DEGARELIX vs DELANDISTROGENE MOXEPARVOVEC-ROKL
DEGARELIX vs DELAVIRDINE
DEGARELIX vs DELORAZEPAM